Pharmacy regulator signs up to shared anti-racism principles The General Pharmaceutical Council is one of nine regulators who have committed to ensuring improved collective accountability to tackle inequalities.…
More than one-quarter of community pharmacies have designated sustainability champion, says GPhC Pharmacy staff rated sustainability as a priority, with a mean score of 6.79 out of 10, according to the GPhC's thematic review.…
NHS to start testing prototype of single national formulary in June 2026 Delegates at the Clinical Pharmacy Congress 2026 heard that the test phase of the single national formerly prototype will begin alongside the development of draft national guidance on local formulary standardisation.…
Royal College of Pharmacy calls for full pharmacy student access to Learning Support Fund In a joint letter to health minister Karin Smyth, pharmacy bodies said pharmacists “should be given comparable access to the training and development support provided to other healthcare professions”.…
OTC medicines spend reduced for second year running Office for National Statistics figures show that real-terms spending on over-the-counter medicines in 2024 was £7.6bn, down from £8.1bn in 2023.…
National formulary should be integrated into electronic prescribing, paediatric bodies say A joint position statement recommended that British National Formulary for Children-based dosing should be used to calculate paediatric doses and set safety dose limits for electronic prescribing systems.…
Nasal decongestant spray use limited to five days The Medicines and Healthcare products Regulatory Agency said that the new rules follow reports of rebound congestion related to prolonged use.…
Seven men sentenced after MHRA seizes 130,000 doses of unauthorised medicines Enforcement action carried out by the Medicines and Healthcare products Regulatory Agency has led to seizure of more than 130,000 doses of unauthorised medicines.…
Apixaban linked to lower risk of recurrent blood clots compared with warfarin Compared with warfarin, people in both frail and non-frail cohorts taking apixaban experienced an average of 12.1 fewer days of home time loss, a study found.…
Legislation to speed up clinical trials comes into force The law change enables researchers to simultaneously apply for ethics and regulatory approval for new clinical trials of investigational medicinal products.…
